Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at Truist Securities
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $64.69 -3.19%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 0 | New: 9
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 0 | New: 9
Join SI Premium – FREE
Truist Securities raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $66.00 (from $65.00) while maintaining a Hold rating.
You May Also Be Interested In
- BMS myeloma CAR T therapy meets primary endpoint in phase 2 trial
- Prada SpA (1913:HK) (PRDSY) PT Lowered to HK$47 at HSBC
- JCDecaux SA (DEC:FP) (JCDXF) PT Raised to EUR34 at JPMorgan, Placed on Positive Catalyst Watch
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
